Concepedia

Author

Johannes Atta

Goethe University Frankfurt

Also Known As

J. R. Atta, Johannes Atta

27

Publications

322

Citations

10

H-Index

8

Concepts

All Affiliations

Goethe University FrankfurtUniversity Hospital FrankfurtUniversity Hospital CologneHeidelberg UniversitySaarland University
JA

About

Johannes Atta is an author at Goethe University Frankfurt specializing in marrow transplantation, radiation oncology, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

19

2

Medicine

1

1

19

3

Marrow Transplantation

1

1

19

4

Hematology

1

1

19

5

Transplantation

1

1

19

Johannes Atta

×

11

Publications

282

Citations

10

H-Index

YearCitations

Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl–positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571)

Urban Scheuring, Patrick T. Bruck, Johannes Atta,

Blood

2002

75

Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib

Urban Scheuring, Anja Binckebanck, Nicola Gökbuget,

Blood

2003

50

Burkitt post‐transplantation lymphoma in adult solid organ transplant recipients

Heiner Zimmermann, Petra Reinke, R. Neuhaus,

Cancer

2012

36

Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (<scp>GHSG</scp>) phase‐I trial

Boris Böll, Annette Plütschow, Carolin Bürkle,

British Journal of Haematology

2018

25

High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation

Gesine Bug, Johannes Atta, Stefan Klein,

Annals of Hematology

2005

19

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on An Ongoing Phase I/II Trial

Ulrich Keller, Johannes Atta, Christian Buske,

Blood

2011

18

Compound GW506U78 Has High Single-Drug Activity and Good Feasibility in Heavily Pretreated Relapsed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LBL) and Offers the Option for Cure with Stem Cell Transplantation (SCT).

Nicola Goekbuget, Renate Arnold, Johannes Atta,

Blood

2005

15

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma

Karola Wagner, Ulrich Keller, Paul La Rosée,

HemaSphere

2020

13

Prostate cancer infiltrating the bladder sphincter successfully treated with Electrochemotherapy: a case report

Nina Klein, Enric Günther, S Zapf,

Clinical Case Reports

2017

11

German Hodgkin Study Group Phase I Trial Of Doxorubicin, Vinblastine, Dacarbazine, and Lenalidomide (AVD-Rev) For Older Hodgkin Lymphoma Patients

Boris Böll, Annette Plütschow, Michael Fuchs,

Blood

2013

10

Page 1